Jiangsu Sainty Corp Ltd
SSE:600287
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Sainty Corp Ltd
SSE:600287
|
CN |
|
N
|
Ningxia Zhongke Biotechnology Co Ltd
SSE:600165
|
CN |
|
K
|
Kuehne und Nagel International AG
XBER:KNIA
|
CH |
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Sainty Corp Ltd's stock price target?
Not Available
Jiangsu Sainty Corp Ltd doesn't have any price targets made by Wall Street professionals.
What is Jiangsu Sainty Corp Ltd's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Jiangsu Sainty Corp Ltd's revenue is
-5%.
The projected
CAGR
for the next 10 years is
7%.
What is Jiangsu Sainty Corp Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Jiangsu Sainty Corp Ltd's operating income is
5%.
The projected
CAGR
for the next 10 years is
9%.
What is Jiangsu Sainty Corp Ltd's Net Income forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Jiangsu Sainty Corp Ltd's net income is
2%.
The projected
CAGR
for the next 10 years is
6%.